RxDoctor Payments Data

Nicole Whitman

Family · Biloxi, MSNPI 1063866937

Payments from drug & device makers

$1,774in general payments, 2019–2025

Across 108 payments — averaging $16.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$316
  • GSK$189
  • Lilly USA, LLC$175
  • Biohaven Pharmaceutical Holding Company Ltd.$126
  • Novo Nordisk$121
  • Johnson & Johnson$103
  • plus $743 from 16 others

What the payments were for

  • Food & beverage$1,774100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,774 in reported general payments places this provider in the 75th percentile of 3,007 family providers in Mississippi.

See all family providers in Mississippi

Medicare billing

Part B allowed, 2024
$42,979
Medicare patients
434
Services billed
618

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$8,928
Doxycycline Hyclate160$1,315
Albuterol Sulfate HfaAlbuterol Sulfate43$1,252
Fluticasone Propionate77$784
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav52$699
Ventolin HfaAlbuterol Sulfate12$625
Cefdinir26$438
Methylprednisolone56$338
CefuroximeCefuroxime Axetil26$338
Azithromycin45$325
Mupirocin34$315
Amoxicillin45$258
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst18$229
Prednisone134$223
Nystatin14$192

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta$189$8,92814 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,007 family providers in Mississippi.

Other family in Biloxi

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →